PUBLISHER: Persistence Market Research | PRODUCT CODE: 1563085

PUBLISHER: Persistence Market Research | PRODUCT CODE: 1563085

Shrimp Disease Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

PUBLISHED: September 25, 2024

PAGES: 215 Pages

DELIVERY TIME: 2-5 business days

ADD TO COMPARE

SELECT AN OPTION

Description

Persistence Market Research has recently released a comprehensive report on the global Shrimp Disease Diagnostics Market, providing an in-depth analysis of key market dynamics, including drivers, trends, opportunities, and challenges. This detailed report sheds light on the market structure and growth potential over the forecast period.

Key Insights:

Shrimp Disease Diagnostics Market Size (2024E): US$500.9 million
Projected Market Value (2033F): US$821 million
Global Market Growth Rate (CAGR 2024 to 2033): 5.6%

Shrimp Disease Diagnostics Market - Report Scope:

The Shrimp Disease Diagnostics Market focuses on the development and application of diagnostic tests for various diseases affecting shrimp, which are vital to aquaculture. The market encompasses various diagnostic methods, including molecular diagnostics, immunodiagnostics, and biochemical tests. Key growth drivers include the rising global demand for shrimp, increasing aquaculture activities, and the need for sustainable shrimp farming practices.

Market Growth Drivers:

Several key factors are driving the growth of the global Shrimp Disease Diagnostics Market. The increasing global demand for shrimp, fueled by rising consumption and exports, is a significant contributor. Furthermore, the need to maintain healthy shrimp populations to ensure productivity and profitability in aquaculture is pushing the adoption of diagnostic solutions. Increased awareness of disease management and prevention among shrimp farmers also supports market growth.

Market Restraints:

Despite its growth potential, the Shrimp Disease Diagnostics Market faces several challenges. High costs associated with advanced diagnostic technologies can limit their adoption, especially among small-scale farmers. Additionally, a lack of standardized testing protocols and limited awareness of available diagnostic solutions can hinder market expansion. Regulatory challenges and the varying prevalence of shrimp diseases across regions may also pose significant barriers.

Market Opportunities:

The Shrimp Disease Diagnostics Market presents substantial growth opportunities, particularly through advancements in technology. Innovations in molecular diagnostics, such as PCR-based tests, are expected to enhance disease detection capabilities. Collaborations between diagnostic companies and aquaculture stakeholders can drive innovation and expand market reach. Furthermore, increasing investment in research and development to create cost-effective and user-friendly diagnostic tools presents further opportunities for growth.

Key Questions Answered in the Report:

What are the primary factors driving the global Shrimp Disease Diagnostics Market?
Which regions are witnessing the highest adoption of shrimp disease diagnostics, and what trends are influencing this growth?
How are advancements in diagnostic technologies impacting the competitive landscape?
Who are the leading players in the Shrimp Disease Diagnostics Market, and what strategies are they implementing to maintain their market positions?
What are the emerging trends and future prospects in the global Shrimp Disease Diagnostics Market?

Competitive Intelligence and Business Strategy:

Leading players in the Shrimp Disease Diagnostics Market, including companies like IDEXX Laboratories, Neogen Corporation, and Thermo Fisher Scientific, are focusing on innovation, research and development, and strategic partnerships to strengthen their market positions. These companies are investing in the development of advanced diagnostic solutions and enhancing their distribution networks. Collaborations with aquaculture stakeholders, research institutions, and regulatory bodies are crucial for market penetration and sustained growth. Ensuring compliance with global regulatory standards and addressing the unique needs of shrimp farmers will help these companies maintain a competitive edge and achieve long-term success in the Shrimp Disease Diagnostics Market.

Key Companies Profiled:

HiMedia Laboratories
HiMedia Laboratories
Speedy Assay Sdn Bhd
REAGEN LLC
FUJIKURA KASEI CO., LTD.
GeneReach Biotechnology Corp.
Thermo Fisher Scientific
Lab - Ind Resource Sdn Bhd.
SUREBIO
Auro Biotechnologies Pvt. Ltd.

Key Segments Covered in Shrimp disease diagnostics Industry Research

Reagent:

Rapid Testing Kits
Assay Based Kits

Disease:

WSSV (White Spot Syndrome Virus)
TSV (Taura Syndrome Virus)
YHV/GAV (Yellow Head/Gill Associated Virus)
IHHNV (Infectious Hypodermal and Hematopoietic Virus)
HPV (Hepatopancreatic Parvovirus)
MBV (Monodon Baculovirus)
IMNV (Infectious Myonecrosis Virus)
NHP-B (Necrotising Hepatopancreatitis Bacteria)
MoV (Mourilyan Virus)
Early Mortality Syndrome (EMS)

End User:

Fisheries
Aquaculture Laboratories
Marine Laboratories
Education and Research Institutes

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

Product Code: PMRREP29626

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Market Innovation / Development Trends

4. Key Success Factors

4.1. Product Adoption Analysis
4.2. Recent Product Approvals
4.3. Regulatory Landscape
4.4. Reimbursement Scenario
4.5. Supply Chain Analysis
4.6. Porter's Analysis
4.7. PESTLE Analysis

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP outlook
- 5.1.2. Global Healthcare Expenditure Outlook
- 5.1.3. Global Animal Diagnostics Market Outlook
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Growing Healthcare Expenditure
- 5.2.2. Historic and Current Revenue of Key Players
- 5.2.3. Increasing Adoption of Diagnostic Tools
- 5.2.4. Rising Incidences of Infectious Diseases
- 5.2.5. Introduction of New and Advance Reagent Kits and Devices
- 5.2.6. High Cost of Diagnostic kits
- 5.2.7. Increasing Research and Development Activities to Develop Diagnostic Tools
- 5.2.8. Strategic Collaboration Among Players
5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis
- 6.1.1. By Reagent Kits
- 6.1.2. By Disease
- 6.1.3. By End User
- 6.1.4. By Country
6.2. 2024 Market Scenario

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
7.2. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Reagent Kits

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis by Reagent Kits, 2019-2023
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Reagent Kits, 2024-2033
- 8.3.1. Rapid Testing Kits
- 8.3.2. Assay Based Kits
8.4. Market Attractiveness Analysis by Reagent Kits

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Disease

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis by Disease, 2019-2023
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Disease, 2024-2033
- 9.3.1. WSSV (White Spot Syndrome Virus)
- 9.3.2. TSV (Taura Syndrome Virus)
- 9.3.3. YHV/GAV (Yellow Head/Gill Associated Virus)
- 9.3.4. IHHNV (Infectious Hypodermal and Hematopoietic Virus)
- 9.3.5. HPV (Hepatopancreatic Parvovirus)
- 9.3.6. MBV (Monodon Baculovirus)
- 9.3.7. IMNV (Infectious Myonecrosis Virus)
- 9.3.8. NHP-B (Necrotising Hepatopancreatitis Bacteria)
- 9.3.9. MoV (Mourilyan Virus)
- 9.3.10. Early Mortality Syndrome (EMS)
9.4. Market Attractiveness Analysis by Disease

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2023
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2024-2033
- 10.3.1. Fisheries
- 10.3.2. Aquaculture Laboratories
- 10.3.3. Marine Laboratories
- 10.3.4. Education and Research Institutes
- 10.3.5. Others
10.4. Market Attractiveness Analysis by End User

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis, by Region, 2019-2023
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Region, 2024-2033
- 11.3.1. North America
- 11.3.2. Latin America
- 11.3.3. Europe
- 11.3.4. East Asia
- 11.3.5. South Asia
- 11.3.6. Oceania
- 11.3.7. Middle East & Africa
11.4. Market Attractiveness Analysis by Region

12. North America Market Analysis 2019-2023 and Forecast 2024-2033

12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
- 12.3.1. By Country
  - 12.3.1.1. U.S.
  - 12.3.1.2. Canada
- 12.3.2. By Reagent Kits
- 12.3.3. By Disease
- 12.3.4. By End User
12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Reagent Kits
- 12.4.3. By Disease
- 12.4.4. By End User
12.5. Market Trends
12.6. Key Market Participants - Intensity Mapping
12.7. Drivers and Restraints - Impact Analysis
12.8. Country Level Analysis & Forecast
- 12.8.1. U.S. Market
  - 12.8.1.1. Introduction
  - 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 12.8.1.2.1. By Reagent Kits
    - 12.8.1.2.2. By Disease
    - 12.8.1.2.3. By End User
- 12.8.2. Canada Market
  - 12.8.2.1. Introduction
  - 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 12.8.2.2.1. By Reagent Kits
    - 12.8.2.2.2. By Disease
    - 12.8.2.2.3. By End User

13. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
- 13.3.1. By Country
  - 13.3.1.1. Mexico
  - 13.3.1.2. Brazil
  - 13.3.1.3. Argentina
  - 13.3.1.4. Rest of Latin America
- 13.3.2. By Reagent Kits
- 13.3.3. By Disease
- 13.3.4. By End User
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Reagent Kits
- 13.4.3. By Disease
- 13.4.4. By End User
13.5. Market Trends
13.6. Key Market Participants - Intensity Mapping
13.7. Drivers and Restraints - Impact Analysis
13.8. Country Level Analysis & Forecast
- 13.8.1. Mexico Market Analysis
  - 13.8.1.1. Introduction
  - 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.1.2.1. By Reagent Kits
    - 13.8.1.2.2. By Disease
    - 13.8.1.2.3. By End User
- 13.8.2. Brazil Market Analysis
  - 13.8.2.1. Introduction
  - 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.2.2.1. By Reagent Kits
    - 13.8.2.2.2. By Disease
    - 13.8.2.2.3. By End User
- 13.8.3. Argentina Market Analysis
  - 13.8.3.1. Introduction
  - 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 13.8.3.2.1. By Reagent Kits
    - 13.8.3.2.2. By Disease
    - 13.8.3.2.3. By End User

14. Europe Market Analysis 2019-2023 and Forecast 2024-2033

14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
- 14.3.1. By Country
  - 14.3.1.1. Germany
  - 14.3.1.2. Italy
  - 14.3.1.3. France
  - 14.3.1.4. U.K.
  - 14.3.1.5. Spain
  - 14.3.1.6. BENELUX
  - 14.3.1.7. Russia
  - 14.3.1.8. Rest of Europe
- 14.3.2. By Reagent Kits
- 14.3.3. By Disease
- 14.3.4. By End User
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Reagent Kits
- 14.4.3. By Disease
- 14.4.4. By End User
14.5. Market Trends
14.6. Key Market Participants - Intensity Mapping
14.7. Drivers and Restraints - Impact Analysis
14.8. Country Level Analysis & Forecast
- 14.8.1. Germany Market Analysis
  - 14.8.1.1. Introduction
  - 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.1.2.1. By Reagent Kits
    - 14.8.1.2.2. By Disease
    - 14.8.1.2.3. By End User
- 14.8.2. Italy Market Analysis
  - 14.8.2.1. Introduction
  - 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.2.2.1. By Reagent Kits
    - 14.8.2.2.2. By Disease
    - 14.8.2.2.3. By End User
- 14.8.3. France Market Analysis
  - 14.8.3.1. Introduction
  - 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.3.2.1. By Reagent Kits
    - 14.8.3.2.2. By Disease
    - 14.8.3.2.3. By End User
- 14.8.4. U.K. Market Analysis
  - 14.8.4.1. Introduction
  - 14.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.4.2.1. By Reagent Kits
    - 14.8.4.2.2. By Disease
    - 14.8.4.2.3. By End User
- 14.8.5. Spain Market Analysis
  - 14.8.5.1. Introduction
  - 14.8.5.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.5.2.1. By Reagent Kits
    - 14.8.5.2.2. By Disease
    - 14.8.5.2.3. By End User
- 14.8.6. BENELUX Market Analysis
  - 14.8.6.1. Introduction
  - 14.8.6.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.6.2.1. By Reagent Kits
    - 14.8.6.2.2. By Disease
    - 14.8.6.2.3. By End User
- 14.8.7. Russia Market Analysis
  - 14.8.7.1. Introduction
  - 14.8.7.2. Market Analysis and Forecast by Market Taxonomy
    - 14.8.7.2.1. By Reagent Kits
    - 14.8.7.2.2. By Disease
    - 14.8.7.2.3. By End User

15. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
- 15.3.1. By Country
  - 15.3.1.1. China
  - 15.3.1.2. Japan
  - 15.3.1.3. South Korea
- 15.3.2. By Reagent Kits
- 15.3.3. By Disease
- 15.3.4. By End User
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Reagent Kits
- 15.4.3. By Disease
- 15.4.4. By End User
15.5. Market Trends
15.6. Key Market Participants - Intensity Mapping
15.7. Drivers and Restraints - Impact Analysis
15.8. Country Level Analysis & Forecast
- 15.8.1. China Market Analysis
  - 15.8.1.1. Introduction
  - 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.1.2.1. By Reagent Kits
    - 15.8.1.2.2. By Disease
    - 15.8.1.2.3. By End User
- 15.8.2. Japan Market Analysis
  - 15.8.2.1. Introduction
  - 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.2.2.1. By Reagent Kits
    - 15.8.2.2.2. By Disease
    - 15.8.2.2.3. By End User
- 15.8.3. South Korea Market Analysis
  - 15.8.3.1. Introduction
  - 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 15.8.3.2.1. By Reagent Kits
    - 15.8.3.2.2. By Disease
    - 15.8.3.2.3. By End User

16. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
- 16.3.1. By Country
  - 16.3.1.1. India
  - 16.3.1.2. Indonesia
  - 16.3.1.3. Malaysia
  - 16.3.1.4. Thailand
  - 16.3.1.5. Rest of South Asia
- 16.3.2. By Reagent Kits
- 16.3.3. By Disease
- 16.3.4. By End User
16.4. Market Attractiveness Analysis
- 16.4.1. By Reagent Kits
- 16.4.2. By Disease
- 16.4.3. By End User
16.5. Market Trends
16.6. Key Market Participants - Intensity Mapping
16.7. Drivers and Restraints - Impact Analysis
16.8. Country Level Analysis & Forecast
- 16.8.1. India Market Analysis
  - 16.8.1.1. Introduction
  - 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.1.2.1. By Reagent Kits
    - 16.8.1.2.2. By Disease
    - 16.8.1.2.3. By End User
- 16.8.2. Indonesia Market Analysis
  - 16.8.2.1. Introduction
  - 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.2.2.1. By Reagent Kits
    - 16.8.2.2.2. By Disease
    - 16.8.2.2.3. By End User
- 16.8.3. Malaysia Market Analysis
  - 16.8.3.1. Introduction
  - 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.3.2.1. By Reagent Kits
    - 16.8.3.2.2. By Disease
    - 16.8.3.2.3. By End User
- 16.8.4. Thailand Market Analysis
  - 16.8.4.1. Introduction
  - 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 16.8.4.2.1. By Reagent Kits
    - 16.8.4.2.2. By Disease
    - 16.8.4.2.3. By End User

17. Oceania Market 2019-2023 and Forecast 2024-2033

17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
- 17.3.1. By Country
  - 17.3.1.1. Australia
  - 17.3.1.2. New Zealand
- 17.3.2. By Reagent Kits
- 17.3.3. By Disease
- 17.3.4. By End User
17.4. Market Attractiveness Analysis
- 17.4.1. By Reagent Kits
- 17.4.2. By Disease
- 17.4.3. By End User
17.5. Market Trends
17.6. Key Market Participants - Intensity Mapping
17.7. Drivers and Restraints - Impact Analysis
17.8. Country Level Analysis & Forecast
- 17.8.1. Australia Market Analysis
  - 17.8.1.1. Introduction
  - 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.1.2.1. By Reagent Kits
    - 17.8.1.2.2. By Disease
    - 17.8.1.2.3. By End User
- 17.8.2. New Zealand Market Analysis
  - 17.8.2.1. Introduction
  - 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 17.8.2.2.1. By Reagent Kits
    - 17.8.2.2.2. By Disease
    - 17.8.2.2.3. By End User

18. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

18.1. Introduction
18.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Market Taxonomy, 2024-2033
- 18.3.1. By Country
  - 18.3.1.1. GCC Countries
  - 18.3.1.2. Turkiye
  - 18.3.1.3. North Africa
  - 18.3.1.4. South Africa
  - 18.3.1.5. Rest of Middle East and Africa
- 18.3.2. By Reagent Kits
- 18.3.3. By Disease
- 18.3.4. By End User
18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Reagent Kits
- 18.4.3. By Disease
- 18.4.4. By End User
18.5. Market Trends
18.6. Key Market Participants - Intensity Mapping
18.7. Drivers and Restraints - Impact Analysis
18.8. Country Level Analysis & Forecast
- 18.8.1. GCC Countries Market Analysis
  - 18.8.1.1. Introduction
  - 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.1.2.1. By Reagent Kits
    - 18.8.1.2.2. By Disease
    - 18.8.1.2.3. By End User
- 18.8.2. Turkiye Market Analysis
  - 18.8.2.1. Introduction
  - 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.2.2.1. By Reagent Kits
    - 18.8.2.2.2. By Disease
    - 18.8.2.2.3. By End User
- 18.8.3. South Africa Market Analysis
  - 18.8.3.1. Introduction
  - 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.3.2.1. By Reagent Kits
    - 18.8.3.2.2. By Disease
    - 18.8.3.2.3. By End User
- 18.8.4. North Africa Market Analysis
  - 18.8.4.1. Introduction
  - 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
    - 18.8.4.2.1. By Reagent Kits
    - 18.8.4.2.2. By Disease
    - 18.8.4.2.3. By End User

19. Market Structure Analysis

19.1. Market Analysis by Tier of Companies
19.2. Market Share Analysis of Top Players
19.3. Market Presence Analysis

20. Competition Analysis

20.1. Competition Dashboard
20.2. Branding and Promotional Strategies
20.3. Key Development Analysis
20.4. Competition Deep Dive
- 20.4.1. HiMedia Laboratories
  - 20.4.1.1. Overview
  - 20.4.1.2. Product Portfolio
  - 20.4.1.3. Sales Footprint
  - 20.4.1.4. Key Financials
  - 20.4.1.5. SWOT Analysis
  - 20.4.1.6. Strategy Overview
    - 20.4.1.6.1. Marketing Strategy
    - 20.4.1.6.2. Product Strategy
    - 20.4.1.6.3. Channel Strategy
- 20.4.2. HiMedia Laboratories
  - 20.4.2.1. Overview
  - 20.4.2.2. Product Portfolio
  - 20.4.2.3. Sales Footprint
  - 20.4.2.4. Key Financials
  - 20.4.2.5. SWOT Analysis
  - 20.4.2.6. Strategy Overview
    - 20.4.2.6.1. Marketing Strategy
    - 20.4.2.6.2. Product Strategy
    - 20.4.2.6.3. Channel Strategy
- 20.4.3. Speedy Assay Sdn Bhd
  - 20.4.3.1. Overview
  - 20.4.3.2. Product Portfolio
  - 20.4.3.3. Sales Footprint
  - 20.4.3.4. Key Financials
  - 20.4.3.5. SWOT Analysis
  - 20.4.3.6. Strategy Overview
    - 20.4.3.6.1. Marketing Strategy
    - 20.4.3.6.2. Product Strategy
    - 20.4.3.6.3. Channel Strategy
- 20.4.4. REAGEN LLC
  - 20.4.4.1. Overview
  - 20.4.4.2. Product Portfolio
  - 20.4.4.3. Sales Footprint
  - 20.4.4.4. Key Financials
  - 20.4.4.5. SWOT Analysis
  - 20.4.4.6. Strategy Overview
    - 20.4.4.6.1. Marketing Strategy
    - 20.4.4.6.2. Product Strategy
    - 20.4.4.6.3. Channel Strategy
- 20.4.5. FUJIKURA KASEI CO., LTD.
  - 20.4.5.1. Overview
  - 20.4.5.2. Product Portfolio
  - 20.4.5.3. Sales Footprint
  - 20.4.5.4. Key Financials
  - 20.4.5.5. SWOT Analysis
  - 20.4.5.6. Strategy Overview
    - 20.4.5.6.1. Marketing Strategy
    - 20.4.5.6.2. Product Strategy
    - 20.4.5.6.3. Channel Strategy
- 20.4.6. GeneReach Biotechnology Corp.
  - 20.4.6.1. Overview
  - 20.4.6.2. Product Portfolio
  - 20.4.6.3. Sales Footprint
  - 20.4.6.4. Key Financials
  - 20.4.6.5. SWOT Analysis
  - 20.4.6.6. Strategy Overview
    - 20.4.6.6.1. Marketing Strategy
    - 20.4.6.6.2. Product Strategy
    - 20.4.6.6.3. Channel Strategy
- 20.4.7. Thermo Fisher Scientific
  - 20.4.7.1. Overview
  - 20.4.7.2. Product Portfolio
  - 20.4.7.3. Sales Footprint
  - 20.4.7.4. Key Financials
  - 20.4.7.5. SWOT Analysis
  - 20.4.7.6. Strategy Overview
    - 20.4.7.6.1. Marketing Strategy
    - 20.4.7.6.2. Product Strategy
    - 20.4.7.6.3. Channel Strategy
- 20.4.8. Lab - Ind Resource Sdn Bhd.
  - 20.4.8.1. Overview
  - 20.4.8.2. Product Portfolio
  - 20.4.8.3. Sales Footprint
  - 20.4.8.4. Key Financials
  - 20.4.8.5. SWOT Analysis
  - 20.4.8.6. Strategy Overview
    - 20.4.8.6.1. Marketing Strategy
    - 20.4.8.6.2. Product Strategy
    - 20.4.8.6.3. Channel Strategy
- 20.4.9. SUREBIO
  - 20.4.9.1. Overview
  - 20.4.9.2. Product Portfolio
  - 20.4.9.3. Sales Footprint
  - 20.4.9.4. Key Financials
  - 20.4.9.5. SWOT Analysis
  - 20.4.9.6. Strategy Overview
    - 20.4.9.6.1. Marketing Strategy
    - 20.4.9.6.2. Product Strategy
    - 20.4.9.6.3. Channel Strategy
- 20.4.10. Auro Biotechnologies Pvt. Ltd.
  - 20.4.10.1. Overview
  - 20.4.10.2. Product Portfolio
  - 20.4.10.3. Sales Footprint
  - 20.4.10.4. Key Financials
  - 20.4.10.5. SWOT Analysis
  - 20.4.10.6. Strategy Overview
    - 20.4.10.6.1. Marketing Strategy
    - 20.4.10.6.2. Product Strategy
    - 20.4.10.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology

Have a question?

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Christine Sirois

Manager - Americas

+1-860-674-8796

SEE OUR FAQ